Did you know that the future of hemp- and cannabidiol (CBD)-based products could be in jeopardy? In July 2020, the European Commission issued a surprising preliminary conclusion that CBD, the non-psychoactive cannabinoid regularly used in food, wellness supplements, and skincare products, should be considered a narcotic drug under the United Nations Single Convention.